Westlake BioPartners Fund I, L.P. ("Westlake Fund I") 13D and 13G filings for Kyverna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 3:17 pm Purchase | 2025-12-31 | 13G | Kyverna Therapeutics, Inc. KYTX | Westlake BioPartners Fund I, L.P. ("Westlake Fund I") | 4,657,257 7.800% | 133,333 (+2.95%) | Filing |
| 2024-11-12 07:23 am Purchase | 2024-09-30 | 13G | Kyverna Therapeutics, Inc. KYTX | Westlake BioPartners Fund I, L.P. ("Westlake Fund I") | 4,523,924 10.500% | 4,523,924 (New Position) | Filing |